ETF Managers Group Cannabis Research and Banking Expert Jason Wilson in Cannabis Business Times

Cannabis Reform Slogs Through Congress as Corporate Revenues Continue to Tumble

Revenue slows and stocks crash despite continued industry growth. Can legislation save small cannabis businesses?

The North American corporate cannabis sector has seen better days. Pandemic-galvanized sales surges are now mostly in the rearview mirror, and markets in large U.S. states and Canada have matured at a rapid clip. Despite the introduction of a new decriminalization bill, a lack of meaningful federal movement makes it feel like the industry is stuck at a crossroads.

As we move into the second half of the year, let’s look at how things have gone for major U.S. and Canadian cannabis companies in 2022 and what we can expect going forward. For expert insight, Cannabis Business Times spoke to senior cannabis banking executives and advocacy groups.

Read more here.